A separate investigation examining the influence of CD20 expression on disease outcomes found that individuals with newly diagnosed, untreated chronic lymphocytic leukemia (CLL) with high levels of CD20 expression experience improved survival without the need for therapy. Here, MS4A1 is linked to B-cell chronic lymphocytic leukemia.